Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | AZN | AMGN | GILD | VRTX |
| Company | Cytokinetics | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 66.49 | 90.69 | 340.36 | 122.29 | 457.78 |
| High | 66.95 | 91.18 | 340.88 | 122.53 | 462.00 |
| Low | 65.36 | 90.07 | 328.63 | 120.38 | 454.45 |
| Latest | 65.67 | 90.18 | 329.89 | 121.22 | 455.48 |
| Change | -0.87 | +0.15 | -10.27 | -1.40 | -1.88 |
| % Change | -1.31% | +0.17% | -3.02% | -1.14% | -0.41% |
| Volume | 1,395,000 | 5,432,900 | 2,897,900 | 10,417,000 | 911,400 |
| 20-Day Average Volume | 1,875,450 | 5,450,140 | 2,883,840 | 7,147,680 | 1,413,700 |
| Previous Close | 66.54 | 90.03 | 340.16 | 122.62 | 457.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 65.55 | 89.84 | 337.49 | 124.35 | 432.99 |
| 20-Day Raw Stochastic | 66.97% | 60.85% | 49.07% | 35.35% | 85.36% |
| 20-Day Relative Strength | 56.73 | 59.22 | 54.49 | 48.14 | 63.04 |
| Weighted Alpha | +19.97 | +36.82 | +23.55 | +29.10 | +2.92 |
| Today's Opinion | 96% Buy | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Previous Opinion | 96% Buy | 100% Buy | 100% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 64% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.61% since 11/28/25 | -2.74% since 11/28/25 | -4.51% since 11/28/25 | -3.67% since 11/28/25 | +5.04% since 11/28/25 |
| Low | 62.58 on 12/02/25 | 89.77 on 12/04/25 | 328.63 on 12/05/25 | 120.38 on 12/05/25 | 423.45 on 12/01/25 |
| High | 67.99 on 12/01/25 | 92.98 on 12/01/25 | 346.38 on 12/03/25 | 126.23 on 12/01/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +10.95% since 11/05/25 | +11.13% since 11/05/25 | +3.14% since 11/05/25 | -1.11% since 11/05/25 | +9.23% since 11/05/25 |
| Low | 58.05 on 11/06/25 | 83.37 on 11/06/25 | 312.52 on 11/06/25 | 117.13 on 11/10/25 | 406.67 on 11/07/25 |
| High | 69.33 on 11/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +23.88% since 09/05/25 | +10.38% since 09/05/25 | +16.31% since 09/05/25 | +5.36% since 09/05/25 | +14.99% since 09/05/25 |
| Low | 47.22 on 09/25/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 69.33 on 11/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +104.71% since 06/05/25 | +24.64% since 06/05/25 | +14.90% since 06/05/25 | +9.74% since 06/05/25 | +2.63% since 06/05/25 |
| Low | 31.99 on 06/23/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 69.33 on 11/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,029,142 | 279,686,592 | 177,639,520 | 150,395,232 | 115,563,928 |
| Shares Outstanding, K | 122,265 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 18,470,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -589,530,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 1,940,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -306,180,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.58 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.54 on 11/05/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/05/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.70 | 15.55 | 14.97 | 29.87 |